Clinical Trials Browser

Ependymoma, Meningioma, Neurilemmoma, Neuroma, Acoustic, Spinal Cord Neoplasms, Neurofibromatoses

NCT01222728 2019-12-17

Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients

Completed

5 enrolled

CNS

Neoplasms, Nervous System Diseases, Neuroma, Acoustic, Vestibular Diseases, Neurofibromatosis 2, Neurofibromatoses

NCT01207687 2018-08-27

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

Phase 2 Completed

14 enrolled 28 charts

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT01119599 2015-09-29

RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Phase 1 Completed

22 enrolled

CNSSarcoma

Astrocytoma, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroma, Acoustic, Oligodendroglioma, Pinealoma, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

NCT00004483 2005-09-29

NF2 Natural History Consortium

Unknown

100 enrolled

CNS

Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Clinical Trials

Natural History Study of Patients With Neurofibromatosis Type 2

Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

NF2 Natural History Consortium